Polyphenols and Flavonoids in Controlling Non-Alcoholic Steatohepatitis

Ravirajsinh N. Jadeja, Ranjitsinh V. Devkar

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Non-alcoholic steatohepatitis (NASH) is defined as an occurrence of fatty liver and related pathological consequences in non-alcoholic individuals. The understanding pertaining to NASH was first introduced in 1980 by Ludwig et al. (Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;. 55(7):434-438), but since then, there has been a serious scarcity of scientific information in this research area. However, the last decade has witnessed some research to decipher underlying mechanism of onset and progression of NASH and its possible therapeutic interventions. Existing treatment paradigms includes modification of life style, coupled with usage of antidiabetic or anti-obesity drugs and antioxidants. Polyphenols and flavonoids have been show to exert beneficial effects in conditions of insulin resistance, obesity and hyperlipidemia and hence, use of polyphenols and flavonoids rich extract in treatment of NASH is aptly justified. This chapter is a meticulous compilation of available literature on the beneficial effects of polyphenols and flavonoids in treating NASH. It also discusses the possibilities of the same being developed as effective therapeutic options with minimal side effects.

Original languageEnglish (US)
Title of host publicationPolyphenols in Human Health and Disease
PublisherElsevier Inc.
Pages615-623
Number of pages9
Volume1
ISBN (Print)9780123984562
DOIs
StatePublished - Nov 1 2013
Externally publishedYes

Fingerprint

Polyphenols
Fatty Liver
Flavonoids
Anti-Obesity Agents
Hyperlipidemias
Research
Hypoglycemic Agents
Insulin Resistance
Life Style
Obesity
Antioxidants
Therapeutics

Keywords

  • Flavonoids
  • Herbal medicine
  • Non-alcoholic steatohepatitis
  • Polyphenols

ASJC Scopus subject areas

  • Medicine(all)
  • Dentistry(all)

Cite this

Jadeja, R. N., & Devkar, R. V. (2013). Polyphenols and Flavonoids in Controlling Non-Alcoholic Steatohepatitis. In Polyphenols in Human Health and Disease (Vol. 1, pp. 615-623). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-398456-2.00047-5

Polyphenols and Flavonoids in Controlling Non-Alcoholic Steatohepatitis. / Jadeja, Ravirajsinh N.; Devkar, Ranjitsinh V.

Polyphenols in Human Health and Disease. Vol. 1 Elsevier Inc., 2013. p. 615-623.

Research output: Chapter in Book/Report/Conference proceedingChapter

Jadeja, RN & Devkar, RV 2013, Polyphenols and Flavonoids in Controlling Non-Alcoholic Steatohepatitis. in Polyphenols in Human Health and Disease. vol. 1, Elsevier Inc., pp. 615-623. https://doi.org/10.1016/B978-0-12-398456-2.00047-5
Jadeja RN, Devkar RV. Polyphenols and Flavonoids in Controlling Non-Alcoholic Steatohepatitis. In Polyphenols in Human Health and Disease. Vol. 1. Elsevier Inc. 2013. p. 615-623 https://doi.org/10.1016/B978-0-12-398456-2.00047-5
Jadeja, Ravirajsinh N. ; Devkar, Ranjitsinh V. / Polyphenols and Flavonoids in Controlling Non-Alcoholic Steatohepatitis. Polyphenols in Human Health and Disease. Vol. 1 Elsevier Inc., 2013. pp. 615-623
@inbook{9cffe814d03246649174911a8f2df9c2,
title = "Polyphenols and Flavonoids in Controlling Non-Alcoholic Steatohepatitis",
abstract = "Non-alcoholic steatohepatitis (NASH) is defined as an occurrence of fatty liver and related pathological consequences in non-alcoholic individuals. The understanding pertaining to NASH was first introduced in 1980 by Ludwig et al. (Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;. 55(7):434-438), but since then, there has been a serious scarcity of scientific information in this research area. However, the last decade has witnessed some research to decipher underlying mechanism of onset and progression of NASH and its possible therapeutic interventions. Existing treatment paradigms includes modification of life style, coupled with usage of antidiabetic or anti-obesity drugs and antioxidants. Polyphenols and flavonoids have been show to exert beneficial effects in conditions of insulin resistance, obesity and hyperlipidemia and hence, use of polyphenols and flavonoids rich extract in treatment of NASH is aptly justified. This chapter is a meticulous compilation of available literature on the beneficial effects of polyphenols and flavonoids in treating NASH. It also discusses the possibilities of the same being developed as effective therapeutic options with minimal side effects.",
keywords = "Flavonoids, Herbal medicine, Non-alcoholic steatohepatitis, Polyphenols",
author = "Jadeja, {Ravirajsinh N.} and Devkar, {Ranjitsinh V.}",
year = "2013",
month = "11",
day = "1",
doi = "10.1016/B978-0-12-398456-2.00047-5",
language = "English (US)",
isbn = "9780123984562",
volume = "1",
pages = "615--623",
booktitle = "Polyphenols in Human Health and Disease",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Polyphenols and Flavonoids in Controlling Non-Alcoholic Steatohepatitis

AU - Jadeja, Ravirajsinh N.

AU - Devkar, Ranjitsinh V.

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Non-alcoholic steatohepatitis (NASH) is defined as an occurrence of fatty liver and related pathological consequences in non-alcoholic individuals. The understanding pertaining to NASH was first introduced in 1980 by Ludwig et al. (Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;. 55(7):434-438), but since then, there has been a serious scarcity of scientific information in this research area. However, the last decade has witnessed some research to decipher underlying mechanism of onset and progression of NASH and its possible therapeutic interventions. Existing treatment paradigms includes modification of life style, coupled with usage of antidiabetic or anti-obesity drugs and antioxidants. Polyphenols and flavonoids have been show to exert beneficial effects in conditions of insulin resistance, obesity and hyperlipidemia and hence, use of polyphenols and flavonoids rich extract in treatment of NASH is aptly justified. This chapter is a meticulous compilation of available literature on the beneficial effects of polyphenols and flavonoids in treating NASH. It also discusses the possibilities of the same being developed as effective therapeutic options with minimal side effects.

AB - Non-alcoholic steatohepatitis (NASH) is defined as an occurrence of fatty liver and related pathological consequences in non-alcoholic individuals. The understanding pertaining to NASH was first introduced in 1980 by Ludwig et al. (Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;. 55(7):434-438), but since then, there has been a serious scarcity of scientific information in this research area. However, the last decade has witnessed some research to decipher underlying mechanism of onset and progression of NASH and its possible therapeutic interventions. Existing treatment paradigms includes modification of life style, coupled with usage of antidiabetic or anti-obesity drugs and antioxidants. Polyphenols and flavonoids have been show to exert beneficial effects in conditions of insulin resistance, obesity and hyperlipidemia and hence, use of polyphenols and flavonoids rich extract in treatment of NASH is aptly justified. This chapter is a meticulous compilation of available literature on the beneficial effects of polyphenols and flavonoids in treating NASH. It also discusses the possibilities of the same being developed as effective therapeutic options with minimal side effects.

KW - Flavonoids

KW - Herbal medicine

KW - Non-alcoholic steatohepatitis

KW - Polyphenols

UR - http://www.scopus.com/inward/record.url?scp=84902559744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902559744&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-398456-2.00047-5

DO - 10.1016/B978-0-12-398456-2.00047-5

M3 - Chapter

AN - SCOPUS:84902559744

SN - 9780123984562

VL - 1

SP - 615

EP - 623

BT - Polyphenols in Human Health and Disease

PB - Elsevier Inc.

ER -